Article: In January 2009, the Company Announced Plans to Acquire Wyeth, Another Leading Global Pharmaceutical Company, In A Deal Valued At Around US$68 Billion.

Article: Mylan buying struggling Tennessee pharmaceutical ...
Charleston Daily Mail;  July 26, 2004 ;     659 words ... ... plans to acquire a Tennessee pharmaceutical company in a deal valued at $4 billion. Mylan ... number one domestic generic pharmaceutical company and a leading branded specialty pharmaceutical company with highly complementary ...

Article: Cypress to strengthen product lineup with Proprius acquisition: ...
San Diego Business Journal;  March 3, 2008 ;     700+ words ... ... lineup following the acquisition of privately held specialty pharmaceutical company Proprius Pharmaceuticals Inc. San Diego-based Cypress ... agreement to acquire Proprius, another local company, in a deal valued at up to $75 million, the company said Feb. 25. The ...

Article: Report of Merck Offer Boosts Troubled Pharmaceutical ...
Knight Ridder/Tribune Business News;  May 12, 2001 ;     700+ words ... ... side Friday. The Whitehouse Station company said it would buy genomics firm Rosetta Inpharmatics of Kirkland, Wash., in a deal valued at $620 million. To see more of The Record, or to subscribe to the newspaper, go to http://www.bergen.com (c ...

Article: UPDATE: Japan's Sankyo and Daiichi confirm $7.7 billion merger to ...
Pharma Marketletter;  March 7, 2005 ;     700+ words ... ... drugmakers Sankyo and Daiichi Pharmaceutical confirmed their intention to merge (Marketletter February 28), in a stock deal valued at around 813.0 billion yen ($7.72 billion), and will consolidate their businesses commencing this October. As previously ...

Article: For The Record.(Briefs)(Baxter AG recalled blood thinner ...
Crain's Chicago Business;  March 24, 2008 ;     700+ words ... ... 000 to the inaugural Looptopia last year. Walgreen plans to buy two operators of worksite health centers: I-trax, in a deal valued at $278 million, and Whole Health Management. Terms of that deal were not disclosed. Orit Greenberg is seeking at least ...

Article: Japan's Sankyo and Daiichi confirm $7.7 billion merger to create ...
Pharma Marketletter;  March 7, 2005 ;     700+ words ... ... drugmakers Sankyo and Daiichi Pharmaceutical confirmed their intention to merge (Marketletter February 28), in a stock deal valued at around 813.0 billion yen ($7.72 billion), and will consolidate their businesses commencing this October. As previously ...

Article: ACCESS Oncology, Inc. and Zentaris AG Sign Product Partnership ...
PR Newswire;  September 18, 2002 ;     700+ words ... ... Zentaris, who continued "ACCESS Oncology represents the ideal partner for Zentaris. As a novel boutique pharmaceutical company focused solely in oncology, they are uniquely positioned to deliver the capabilities of a much larger company ...